Ads
related to: retinal pigmentosa treatments and cures for glaucoma surgery- Dosing & Administration
View Dosing Information
& Administration Options.
- About Biosimilars
Review Important Info. View
Full Prescribing & Safety Info
- Clinical Studies
Review Clinical Study
Results for PAVBLU™.
- Help Get Patients Started
See Dosing & Administration Info
For PAVBLU™.
- Clinical Safety Results
Review Safety & Efficacy
Information For PAVBLU™.
- Dosing Information
Find PAVBLU™ Dosing And
Administration Info.
- Dosing & Administration
swissmedica.startstemcells.com has been visited by 10K+ users in the past month
Search results
Results From The WOW.Com Content Network
Glaucoma is a group of diseases affecting the optic nerve that results in vision loss and is frequently characterized by raised intraocular pressure (IOP). There are many glaucoma surgeries, and variations or combinations of those surgeries, that facilitate the escape of excess aqueous humor from the eye to lower intraocular pressure, and a few that lower IOP by decreasing the production of ...
A number of these cell types are implicated in retinal diseases, including retinal ganglion cells, which degenerate in glaucoma, the rod and cone photoreceptors, which are responsive to light and degenerate in retinitis pigmentosa, macular degeneration, and other retinal diseases, and the retinal pigment epithelium (RPE), which supports the ...
The progressive nature of and lack of a definitive cure for retinitis pigmentosa contribute to the inevitably discouraging outlook for patients with this disease. While complete blindness is rare, the person's visual acuity and visual field will continue to decline as initial rod photoreceptor and later cone photoreceptor degradation proceeds.
The quality of vision expected from a retinal implant is largely based on the maximum spatial resolution of the implant. Current prototypes of retinal implants are capable of providing low resolution, pixelated images. "State-of-the-art" retinal implants incorporate 60-100 channels, sufficient for basic object discrimination and recognition tasks.
Ocular’s pipeline also leverages the ELUTYX technology in its commercial product DEXTENZA ®, an FDA-approved corticosteroid for the treatment of ocular inflammation and pain following ophthalmic surgery and ocular itching associated with allergic conjunctivitis, and in its product candidate PAXTRAVA™ (travoprost intracameral injection or ...
Primary open-angle glaucoma PPDR Preproliferative diabetic retinopathy PRA Pan-retinal ablation PRK Photorefractive keratectomy PRP Pan-retinal photocoagulation PSCC Posterior sub-capsular cataract PVD Posterior vitreous detachment PXF Pseudoexfoliative syndrome RD Retinal detachment: RK Radial keratotomy: RP Retinitis pigmentosa: SEAL